Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Anti-cancer efficacy of novel phenolic polymer from Symphytum asperum and S.caucasicum (Boraginaceae) against androgendependent and -independent human prostate cancer cells
2nd International Conference on Analytical & Bioanalytical Techniques
High-molecular (>1000 kDa) preparations from the crude polysaccharides of
Symphytum asperum
and
S.caucasicum
roots were isolated by ultrafi
ltration on
membrane fi
lters with cut-off
values of 1000 kDa and the elucidation of their principal
structural units was carried out. According to IR,
13
C NMR,
1
H NMR, 2D heteronuclear
1
H/
13
C HSQC spectral data the main structural element of these preparations was found
to be a regularly substituted polyoxyethylene, namely poly[oxy-1-carboxy-2-(3,4-
dihydroxyphenyl)ethylene] or poly[3-(3,4-dihydroxyphenyl)glyceric acid] (PDPGA).
Such phenolic biopolymer to our knowledge has not been known
and has been identifi
ed
for the fi
rst time. Th
is compound represents a new class of natural polyethers with a
residue of 3-(3,4-dihydroxyphenyl)glyceric acid as the repeating unit. PDPGA possesses
anticomplementary, antioxidant and anti-infl
ammatory activities.
We examined the effi
cacy of PDPGA of
S.asperum
(PDGPA-SA)
and
S.caucasicum
(PDGPA-SC) in androgen-dependent (LNCaP) and -independent (22Rv1 and PC3)
human prostate cancer (PCA) cells. PDPGA-SA treatment (100 mcg/ml for 48h)
decreases the live cell number by 65, 64 and 35% and increases the cell death by 16, 8 and
12 folds in LNCaP, 22Rv1 and PC3 cells, respectively. Similarly, PDPGA-SC treatment
(100 mcg/ml for 48h) decreased the live cell number by 87, 25 and 33% and increased the
cell death by 19, 10 and 9 folds in LNCaP, 22Rv1 and PC3 cells, respectively.
Overall, present study identifi
ed the strong effi
cacy of these novel phytochemicals
against PCA cells, and suggested that their pre-clinical effi
cacy studies in PCA models
are needed in future to move them forward for possible translational potential in PCA
patients.
Biography
1978 and 1999 has completed his Ph.D and his D.Sci. at the ages of 33 and 54 years from Zelinsky Instiute of Organic Chemistry, Moscow, Russia and Durmishidze Institute of Biochemistry and Biotechnology, Tbilisi, Georgia, respectively. 2006 up to date he is the head of laboratory of plant biopolymers at the Tbilisi State Medical University I.Kutateladze Institute of Pharmacochemistry. 1996 and 2002 he has been a visiting scientist at Utrecht University (faculty of pharmacy, department of pharmacognosy), The Netherlands, by Utrecht University Scholarship and NATO Scienti fi c Program, respectively. He has published more than 50 papers in reputed journals.
Relevant Topics
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, 黑料网 Journals